J Appl Biomed 6:15-18, 2008 | DOI: 10.32725/jab.2008.002

Detection of microsatellite instability in Czech HNPCC patients

Martina Sekowská1,*, Anna Kĝepelová2, Vìra Kebrdlová1
1 Institute of Biology and Medical Genetics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
2 Institute of Biology and Medical Genetics, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic

The detection of microsatellite instability (MSI) is a standard part of mutational analysis in hereditary nonpolyposis colorectal cancers (HNPCC). A characteristic phenotypic feature of MSI indicates loss of mismatch repair (MMR) in tumour cells.
We studied MSI in 205 tumours from 152 patients with HNPCC. Of these, 37 patients fulfilled the Amsterdam criteria, 72 patients were familial and 43 were sporadic cases. We used the method of fragmentation analysis (ABI Prism 310 Genetic Analyzer) with fluorescent labelled primers; three mononucleotide (BAT-RII, BAT-25, BAT-26) and five dinucleotide (D2S123, D3S1029, D5S346, D17S250, D18S58) repeat loci were analysed. We detected 75 tumours with a high degree of MSI (MSI-H), 12 tumours with a low degree of MSI (MSI-L) and 118 tumours with stable microsatellites (MSS). We found a loss of heterozygozity (LOH) in 44 MSS tumours. In 30 patients with MSI-H tumours mutation in one of mismatch repair genes was detected.

Keywords: microsatellite instability; loss of heterozygozity; HNPCC; fragment analysis

Received: August 6, 2007; Revised: October 1, 2007; Published: March 31, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sekowská M, Kĝepelová A, Kebrdlová V. Detection of microsatellite instability in Czech HNPCC patients. J Appl Biomed. 2008;6(1):15-18. doi: 10.32725/jab.2008.002.
Download citation

References

  1. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S: A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58:5248-5257, 1998.
  2. Cawkwell L, Li D, Lewis FA, Martin I, Dixon MF, Quirke P: Microsatellite instability in colorectal cancer: Improved assessment using fluorescent polymerase chain reaction. Gastroenterology 109:465-471, 1995. Go to original source... Go to PubMed...
  3. Dietmaier W, Riedlinger W, Köhler A, Wegele P, Beyser K, Sagner G, Wartbichler R, Rüschoff J: Detection of microsatellite instability (MSI) and loss of heterozygosity (LOH) in colorectal tumors by fluorescence-based multiplex microsatellite PCR. Biochemica 2:42-45, 1999.
  4. Gebert J, Sun M, Ridder R, Hinz U, Lehnert T, Möller P, Schackert HK, Herfarth Ch, Doeberitz MK: Molecular profiling of sporadic colorectal tumors by microsatellite analysis. Int. J. Oncol. 16:169-179, 2000. Go to original source... Go to PubMed...
  5. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, Jass JR, Dunlop M, Wyllie A, Peltomaki P, de la Chapelle A, Hamilton SR et al.: Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat. Med. 2:169-174, 1996. Go to original source... Go to PubMed...
  6. Marra G, Boland CR: DNA repair and colorectal cancer. Gastroenterol. Clin. North Am. 25:755-772, 1996. Go to original source... Go to PubMed...
  7. Plevova P, Krepelova A, Papezova M, Sedlakova E, Curik R, Foretova L, Navratilova M, Novotny J, Zapletalova J, Palas J, Nieslanik J, Horacek J et al.: Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer. Neoplasma 51:275-284, 2004. Go to original source... Go to PubMed...
  8. Thibodeau SN, French AJ, Cunningham JM, Tester D, Burgart LJ, Roche PC, McDonnell SK, Schaid DJ, Vockley CW, Michels VV, Farr GH, O'Connell MJ: Microsatellite instability in colorectal cancer: Different mutator phenotypes and the principal involvement of hMLH1. Cancer Res. 58:1713-1718, 1998.
  9. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis. Colon. Rectum 34:424-425, 1991. Go to original source... Go to PubMed...
  10. Vasen HF, Moslein G, Alonso A, Bernstein I, Bertario L, Blanco I, Burn J, Capella G, Engel C, Frayling I, Friedl W, Hes FJ et al.: Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J. Med. Genet. 44:353-362, 2007. Go to original source... Go to PubMed...
  11. Wu Y, Berends MJW, Mensink RGJ, Kempinga C, Sijmons RH, Zee AGJ, Hollema H, Kleibeuker JH, Buys CHCM, Hofstra RMW: Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am. J. Hum. Genet. 65:1291-1298, 1999. Go to original source... Go to PubMed...